Clinical Roundup Study finds a cause of resistance to revumenib in acute leukemia March 17, 2023Vol.49 No.11
Clinical Roundup Healthy gut bacteria can help fight cancer in other parts of the body, UTSW researchers find March 17, 2023Vol.49 No.11
Drugs & Targets FDA approves Tafinlar + Mekinist for pediatric patients with low-grade glioma with a BRAF V600E mutation March 17, 2023Vol.49 No.11
Drugs & Targets Prelude Therapeutics to collaborate with BeiGene to evaluate PRT2527 + zanubrutinib in hematologic cancers March 17, 2023Vol.49 No.11
Conversation with The Cancer Letter UNM’s Sanchez: To provide cancer care to Native American, Hispanic communities, you must first establish trust March 10, 2023Vol.49 No.10By Paul Goldberg
Regulatory News Improving on R-CHOP, ODAC votes 11:2 to move Genentech’s Polivy to the first line in diffuse large B-cell lymphoma March 10, 2023Vol.49 No.10By Jacquelyn Cobb
White House Biden requests $503M increase for NCI, new funds for the Moonshot, $1B for ARPA-H in FY24 March 10, 2023Vol.49 No.10By Matthew Bin Han Ong
In Brief Raphael Pollock and George Weiner do a “flip-flop,” replacing each other at Big Ten Cancer Research Consortium, ORIEN March 10, 2023Vol.49 No.10
In Brief Rangaswamy Govindarajan named chief of UAMS Hematology and Oncology Division March 10, 2023Vol.49 No.10
